Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Biomarkers for Traumatic Brain Injury
Due to injuries sustained in sports and in combat, interest in traumatic brain injury (TBI) has never been greater. This book will fulfill a gap in understanding of what is occurring in the brain following injury that can subsequently be detected in biological fluids and imaging.
Neurochemistry
Proceedings of the 11th European Society for Neurochemistry Meeting held in Groningen, The Netherlandes, June 15-20, 1996
Current Catalog
First multi-year cumulation covers six years: 1965-70.
Conquering Stroke
"A true story of triumph over tragedy, this book is a must-have guide for anyone affected by stroke." —William S. Maxfield "Valerie Greene's courage, persistence, and willingness to search for the healing energies within her have shifted her body, mind, and spirit. Her story is an inspiration to all." —Donna Eden Stroke is the third leading cause of death in the United States today and the leading cause of adult disability. Now Valerie Greene, a stroke survivor whose recovery surpassed even the most optimistic expectations, uses her own dramatic, inspiring, and eye-opening story to illustrate and deliver the important practical information you and your loved ones need to prevent, recognize, minimize, and recover from stroke.
Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
Topic Editor, Prof. Heinrich Audebert, received funding from institutional funding by Roche Diagnostics International Ltd. and the Berlin Future Funds. The other Topic Editors declare no competing interests with regard to the Research Topic subject.
Acute Brain Impairment
A rise in the number of young and old patients suffering from a stroke or traumatic brain injury has led to the need for better drug development and treatment, as well as diagnosis and prevention of ischemic stroke and traumatic brain injury. This book provides a comprehensive overview of scientific advancements in these areas. Chapters provide the latest knowledge in neuroscience, biotechnology, and personalized medicine applicable to acute brain injuries. Development of neuroprotective drugs is treated in detail. Chemical biomarkers for detection, imaging and preventative strategies are covered to provide medicinal chemists with a broad view of translational aspects of the field. This book will be useful to postgraduate students and researchers in medicinal chemistry and pharmacology as well as specialists in the acute brain injury field.
Update on Amyotrophic Lateral Sclerosis
This book contains selected peer-reviewed chapters which cover updated information on ALS written by international researchers. Update on Amyotrophic Lateral Sclerosis is comprised of 13 chapters from some of the world's top central nervous system researchers and neurologists to provide a timely review of the most recent developments in ALS, covering historic aspects, experimental animal models, genetics, pathogenesis, clinical aspects and imagenology among others. Contributors from Belgium, France, Japan, India, Italy, Mexico, Russia, South Africa, and Switzerland have collaborated enthusiastically and efficiently, dedicating their time to create this reader-friendly yet comprehensive work which includes many explanatory figures, tables and photos to enhance legibility and make the book clinically useful. We are looking forward with confidence and pride in the remarkable role that this book will play for a new vision and mission.
Amyotrophic Lateral Sclerosis
Though considerable amount of research, both pre-clinical and clinical, has been conducted during recent years, Amyotrophic Lateral Sclerosis (ALS) remains one of the mysterious diseases of the 21st century. Great efforts have been made to develop pathophysiological models and to clarify the underlying pathology, and with novel instruments in genetics and transgenic techniques, the aim for finding a durable cure comes into scope. On the other hand, most pharmacological trials failed to show a benefit for ALS patients. In this book, the reader will find a compilation of state-of-the-art reviews about the etiology, epidemiology, and pathophysiology of ALS, the molecular basis of disease progression and clinical manifestations, the genetics familial ALS, as well as novel diagnostic criteria in the field of electrophysiology. An overview over all relevant pharmacological trials in ALS patients is also included, while the book concludes with a discussion on current advances and future trends in ALS research.
